Literature DB >> 28520857

The diffusing capacity of the lung for carbon monoxide is associated with the histopathological aggressiveness of lung adenocarcinoma.

Naoki Ozeki1, Koji Kawaguchi1, Takayuki Fukui1, Koichi Fukumoto1, Shota Nakamura1, Shuhei Hakiri1, Taketo Kato1, Akihiro Hirakawa2, Toshiki Okasaka1, Kohei Yokoi1.   

Abstract

OBJECTIVES: The diffusing capacity of the lung for carbon monoxide (DLCO) is an indicator of lung damage. We sought to determine whether DLCO is associated with the aggressiveness of lung adenocarcinoma using histopathological indexes, such as tumour differentiation, scar grade, nuclear atypia and the mitotic index.
METHODS: Fifty-seven patients with low DLCO (≤80% of predicted) and 466 patients with normal DLCO (>80% of predicted) who underwent R0 resection of lung adenocarcinoma between 2005 and 2012 were retrospectively reviewed. The relationships between the DLCO status and each histopathological index as well as the overall survival were evaluated.
RESULTS: Low DLCO had significant relationships with moderate/poor differentiation (79% vs 57% [low DLCO vs normal DLCO]), scar grade 3/4 (37% vs 18%), nuclear atypia 3 (65% vs 30%) and the mitotic index 3 (26% vs 8%). After adjusting for the age, sex, forced expiratory volume in 1 s, smoking status and tumour size, a low DLCO still showed a significant correlation with the histopathological indexes. These histopathological indexes were all significant factors for the overall survival on log-rank tests. In a multivariable Cox regression analysis with 13 clinicopathological variables, moderate/poor differentiation and nuclear atypia Grade 3 were significant histopathological factors for the overall survival (hazard ratios: 2.16 and 1.84; 95% confidence intervals: 1.10-4.51 and 1.06-3.21; P = 0.024 and 0.029, respectively).
CONCLUSIONS: Our findings regarding the relationship between DLCO and the histopathological indexes of lung adenocarcinoma suggest that lung damage may be associated with carcinogenesis and progression.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  DLCO; Lung adenocarcinoma; Mitotic index; Nuclear atypia; Scar grade; Tumour differentiation

Mesh:

Substances:

Year:  2017        PMID: 28520857     DOI: 10.1093/ejcts/ezx124

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  2 in total

1.  A survival analysis using physique-adjusted tumor size of non-small cell lung cancer.

Authors:  Naoki Ozeki; Takayuki Fukui; Koji Kawaguchi; Shota Nakamura; Shuhei Hakiri; Taketo Kato; Akihiro Hirakawa; Kohei Yokoi
Journal:  Int J Clin Oncol       Date:  2017-11-29       Impact factor: 3.402

2.  Low diffusing capacity, emphysema, or pulmonary fibrosis: who is truly pulling the lung cancer strings?

Authors:  Seshiru Nakazawa; Kimihiro Shimizu; Akira Mogi; Hiroyuki Kuwano
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.